| Series 3 Episode 3: Sustainability (environmental) |
The CPM team discuss environmental sustainability in personalised medicine with Dr Gabrielle Samuel from King's College London. |
Rachel Horton, Gabrielle Samuel, Sarah Briggs, Louisa Chenciner |
25 March, 2025 |
|
| Series 3 Episode 2: Risk and Prevention in Personalised Medicine |
The CPM team discuss the benefits and challenges of personalised prevention approaches with Dr Malte Gerhold from the Health Foundation. |
Rachel Horton, Anneke Lucassen, Sally Sansom, Louisa Chenciner, Malte Gerhold |
17 February, 2025 |
|
| Series 3 Episode 1: What is personalised medicine? |
The CPM team discuss what we mean when we talk about personalised medicine. |
Rachel Horton, Anneke Lucassen, Susie Weller, Ali Kay, Sarah Briggs, Sally Sansom |
24 January, 2025 |
|
| Extra - 2023-24: the year in review |
We discuss the highlights for the CPM in 2023-24, and look forward to the next year. |
Rachel Horton, Anneke Lucassen, Susie Weller, Padraig Dixon |
15 November, 2024 |
|
| Series 2 Episode 8 - Navigating a genetic diagnosis |
What might it be like to navigate a genetic diagnosis and share it with family members? We talk to Julie Young from the CanGene CanVar patient reference panel about her experience. |
Rachel Horton, Gabrielle Samuel, Julie Young |
12 June, 2023 |
|
| Series 2 Episode 7 - Why research regulation falls short in genomic medicine |
As a society, we tend to focus a lot on risk and try to control it through regulation - but how well does that work for ensuring ethical practice in genomics? We talk to Dr Kate Lyle about her research on this topic. |
Rachel Horton, Gabrielle Samuel, Kate Lyle |
2 May, 2023 |
|
| Series 2 Episode 6 - Diversifying genomics |
What are the ethical challenges with diversifying genomic data? We talk to Faranak Hardcastle about her work exploring this. |
Rachel Horton, Gabrielle Samuel, Faranak Hardcastle |
7 March, 2023 |
 |
| Series 2 Episode 5 - Who's 'the patient' in genomic medicine? |
We live our lives alongside others, and our decisions have consequences for those close to us - what does this mean for how we define 'the patient' in genomic medicine? Susie Weller talks to us about this issue. |
Rachel Horton, Gabrielle Samuel, Susie Weller |
25 January, 2023 |
|
| Series 2 Episode 4 - Newborn genome screening |
What sort of findings might we get from newborn genome screening? What might this mean for the NHS? Rachel Horton talks to Gabby Samuel and Lisa Ballard. |
Rachel Horton, Gabrielle Samuel, Lisa Ballard |
20 October, 2022 |
|
| Series 2 Episode 3 - Sharing genetic results within families |
Who does a genetic result belong to? What might help people to share genetic information with their relatives? We talk to Lisa Ballard and Anneke Lucassen. |
Rachel Horton, Gabrielle Samuel, Lisa Ballard, Anneke Lucassen |
16 August, 2022 |
|
| Series 2 Episode 2 - Why context matters in genetic testing |
How can the same genetic finding can mean different things in different people? What does this mean for 'personalising' genetic results? Anneke Lucassen talks to us about this issue. |
Rachel Horton, Gabrielle Samuel, Anneke Lucassen |
18 July, 2022 |
|
| Series 2 Episode 1 - The environmental cost of personalised medicine |
How does personalised medicine impact on the environment? What does this mean for how we should collect and store data? Gabrielle Samuel talks to us about these issues. |
Rachel Horton, Gabrielle Samuel, Susie Weller |
16 June, 2022 |
|
| Series 1 Episode 2 - Meet the Advisory Board: Dame Mary Archer |
In the second episode of the Meet the Advisory Board Series we talked to Dame Mary Archer about personalised medicine in practice, her academic career and her plethora of other roles she has held and is holding at the moment. |
Anika Knuppel, Jiyoon Lee, Dame Mary Archer |
25 June, 2021 |
|
| Series 1 Episode 1 - Meet the Advisory Board: Dr Magdalena Skipper |
In the first episode of the Meet the Advisory Board Series we talked to Dr Magdalena Skipper to find out about her remarkable career in academia, science publishing and her views on personalised medicine. |
Magdalena Skipper |
31 March, 2021 |
|
